Standard
Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy. / Würtz, Anne Mette Lund; Tjønneland, Anne; Christensen, Jane Hvarregaard; Dragsted, Lars Ove; Aarestrup, Julie; Kyrø, Cecilie; Overvad, Kim; Olsen, Anja.
I:
Cancer Causes & Control, Bind 23, Nr. 10, 2012, s. 1711-1720.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Würtz, AML, Tjønneland, A, Christensen, JH
, Dragsted, LO, Aarestrup, J, Kyrø, C, Overvad, K & Olsen, A 2012, '
Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy',
Cancer Causes & Control, bind 23, nr. 10, s. 1711-1720.
https://doi.org/10.1007/s10552-012-0050-7APA
Würtz, A. M. L., Tjønneland, A., Christensen, J. H.
, Dragsted, L. O., Aarestrup, J., Kyrø, C., Overvad, K., & Olsen, A. (2012).
Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
Cancer Causes & Control,
23(10), 1711-1720.
https://doi.org/10.1007/s10552-012-0050-7Vancouver
Würtz AML, Tjønneland A, Christensen JH
, Dragsted LO, Aarestrup J, Kyrø C o.a.
Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
Cancer Causes & Control. 2012;23(10):1711-1720.
https://doi.org/10.1007/s10552-012-0050-7Author
Würtz, Anne Mette Lund ; Tjønneland, Anne ; Christensen, Jane Hvarregaard ; Dragsted, Lars Ove ; Aarestrup, Julie ; Kyrø, Cecilie ; Overvad, Kim ; Olsen, Anja. / Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy. I: Cancer Causes & Control. 2012 ; Bind 23, Nr. 10. s. 1711-1720.
Bibtex
@article{1ee6de1e008644f18bb5171c96ad3f9f,
title = "Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy",
abstract = "Levels of endogenous estrogen and SHBG are associated with risk of breast cancer among women who have never used hormone replacement therapy (HRT). We investigated these associations in both never and baseline users of HRT.",
author = "W{\"u}rtz, {Anne Mette Lund} and Anne Tj{\o}nneland and Christensen, {Jane Hvarregaard} and Dragsted, {Lars Ove} and Julie Aarestrup and Cecilie Kyr{\o} and Kim Overvad and Anja Olsen",
note = "IHE 2012 071",
year = "2012",
doi = "10.1007/s10552-012-0050-7",
language = "English",
volume = "23",
pages = "1711--1720",
journal = "Cancer Causes & Control",
issn = "0957-5243",
publisher = "Springer",
number = "10",
}
RIS
TY - JOUR
T1 - Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy
AU - Würtz, Anne Mette Lund
AU - Tjønneland, Anne
AU - Christensen, Jane Hvarregaard
AU - Dragsted, Lars Ove
AU - Aarestrup, Julie
AU - Kyrø, Cecilie
AU - Overvad, Kim
AU - Olsen, Anja
N1 - IHE 2012 071
PY - 2012
Y1 - 2012
N2 - Levels of endogenous estrogen and SHBG are associated with risk of breast cancer among women who have never used hormone replacement therapy (HRT). We investigated these associations in both never and baseline users of HRT.
AB - Levels of endogenous estrogen and SHBG are associated with risk of breast cancer among women who have never used hormone replacement therapy (HRT). We investigated these associations in both never and baseline users of HRT.
U2 - 10.1007/s10552-012-0050-7
DO - 10.1007/s10552-012-0050-7
M3 - Journal article
C2 - 22926300
VL - 23
SP - 1711
EP - 1720
JO - Cancer Causes & Control
JF - Cancer Causes & Control
SN - 0957-5243
IS - 10
ER -
